Biogen shares drop on Tecfidera patient death
October 22, 2014 at 11:48 AM EDT
Shares of biotechnology giant Biogen Idec Inc. tumble after it’s revealed a patient using its multiple-sclerosis drug Tecfidera has died.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.